The complexities arise from Section 503A of the Federal Food, Drug, and Cosmetic Act, which relates to the necessary conditions for drug compounding.20 The rules concerning the compounding of therapeutic peptides state that they must come from accredited compounding pharmacies, and the compounded drug must either be compounded from an existing FDA-approved drug product or use drug products included on the 503A bulks list (i.e., the FDAs roster of compoundable substances.)21 But many therapeutic peptides dont satisfy either of the 503A conditions
The main application scenarios are as follows
Using the Wrong Water: A researcher once called us wondering why their solution grew cloudy after a few days
This product is distributed solely as a non-medical research material and is not intended for human or veterinary use
Skye Peptides positions itself as a premium vendor with batch-matched COAs, temperature-controlled shipping, and US-based operations
Store at 1525 C in a cool, dry place